Excelsior Medical Co., Ltd.

TWSE:4104.TW

87.8 (TWD) • At close October 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 746.605963.7873.736829.383746.825648.5554.237578.614547.017470.414414.701361447.97434.734358.962
Depreciation & Amortization 265.676222.438202.954167.467160.24180.26784.81596.749125.388123.054123.222130.567131.423100.035100.56
Deferred Income Tax 000-332.142-259.524000-216.292-178.894000-66.9940
Stock Based Compensation 0004.1523.3220002.0426.80900032.0540
Change In Working Capital -789.463-151.789203.89212.913615.784-300.861-919.688-11.475293.624297.296-16.8270.986-1,061.759-534.365291.422
Accounts Receivables -786.424-544.716-538.925308.8631,165.219372.4891,137.656-1,190.026-242.272-20.11426.208154.984000
Inventory -139.988-312.958-121.871-36.471149.01465.661-155.41768.791108.2138.7-144.99413.173-376.45-289.446-136.667
Accounts Payables -27.92452.85765.264-171.23924.795-14.819-199.99119.39431.661000000
Other Working Capital 164.873653.028799.422111.76-723.244-366.522-764.271-80.266185.414258.596128.194257.813-685.309-244.919428.089
Other Non Cash Items 81.425-397.223-335.531-12.34-72.152-235.472-206.752-214.175-11.8218.057-163.646-45.296-46.1581.078-57.432
Operating Cash Flow 304.243637.126945.049869.4331,194.496192.434-487.388449.713739.959736.736357.477717.257-528.524-33.458693.512
Investing Activities:
Investments In Property Plant And Equipment -142.637-172.505-168.754-35.033-52.002-36.229-36.871-31.104-28.417-30.153-89.238-46.08-58.842-303.887-105.195
Acquisitions Net -15.165-837.121153.596-86.241-358.098188.093-102.361-14.278-242.049133.989-569.16-132.705-821.615-188.539-305.303
Purchases Of Investments -665.722-441.456-691.864-722.647-414.149-1,027.056-351.958-1,367.351-1,145.083-781.058-256.5173.333-24.194-223.629-10.132
Sales Maturities Of Investments 700.522541.212947.977366.705195.5061,807.493715.314740.3761,539.427180.922461.269107.51363.67810.5224.752
Other Investing Activites -35.455219.865-96.8362.36686.523523.542201.846360.931109.802148.642-85.11930.895-20.16912.825-336.216
Investing Cash Flow -158.457-690.005144.125-414.85-542.221,455.843425.97-311.426233.68-347.658-538.75832.956-861.142-692.73-532.094
Financing Activities:
Debt Repayment -601.147-55.173-4.055-812.917-398.607-350-9.92-5.707-29.051-348.545-435.552-26.789-16.647-9.2840
Common Stock Issued 000585000113.936299.25000966.049602.9890
Common Stock Repurchased 000-86.1920000-185.685000-18.359835.30
Dividends Paid -540.953-494.021-494.021-465.792-384.447-357.917-319.067-304.451-282.381-225.905-225.905-102.684-257.46-188.363-169.732
Other Financing Activities 0.056-84.695-95.832176.617-101.88-293.81525.782233.979164.869630.454794.85-460.54-92.008440.32194.876
Financing Cash Flow -37.452-633.889-593.908-603.284-884.934-1,001.732-303.205-76.179-32.99856.004133.393-590.013581.5751,680.96225.144
Other Information:
Effect Of Forex Changes On Cash -0.543121.499-41.466-61.611-38.647-20.356-38.251-88.15-11.54719.79210.983-1.75718.499-6.518-15.051
Net Change In Cash 107.791-565.269453.8-210.312-271.305626.189-402.874-26.042929.094464.874-36.905158.443-789.592948.256171.511
Cash At End Of Period 2,614.7862,506.9953,072.2642,618.4642,828.7763,100.0812,473.8922,876.7662,902.8081,973.7141,508.841,735.7451,577.3022,366.8941,418.638